Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.

Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Moorman, A, Richards, S, Martineau, M, Cheung, K, Robinson, H, Jalali, G, Broadfield, Z, Harris, R, Barber, K, Lilleyman, J, Kinsey, S, Eden, O, Vora, A, Mitchell, C, Harrison, C
Ձևաչափ:	Conference item
Հրապարակվել է:	2003

Նմանատիպ նյութեր

Thioguanine-related veno-occlusive disease (VOD) of the liver in children with acute lymphoblastic leukaemia (ALL): Report from United Kingdom Medical Research Council (UK MRC) trial ALL97.
‌: Vora, A, և այլն
Հրապարակվել է: (2002)

Variables affecting kinetics of minimal residual disease clearance in children with lymphoblastic leukaemia; Results of the United Kingdom Medical Research Council (UK MRC) protocols ALL97, ALL97/99 and ALL2003.
‌: Vora, A, և այլն
Հրապարակվել է: (2005)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
‌: Hann, I, և այլն
Հրապարակվել է: (2000)

Benefit of targeted intensification for NCI high risk childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council trial ALL97 and ALL97/99.
‌: Vora, A, և այլն
Հրապարակվել է: (2006)

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
‌: Mitchell, C, և այլն
Հրապարակվել է: (2005)

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
‌: Lennard, L, և այլն
Հրապարակվել է: (2005)

MRC ALL97/99 - A randomized comparison of dexamethasone versus prednisolone and thioguanine versus mercaptopurine in the treatment of childhood acute lymphoblastic leukemia.
‌: Mitchell, C, և այլն
Հրապարակվել է: (2002)

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97.
‌: Moor-Man, A, և այլն
Հրապարակվել է: (2009)

TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis
‌: Moorman, A, և այլն
Հրապարակվել է: (2005)

The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
‌: Mitchell, C, և այլն
Հրապարակվել է: (2009)

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.
‌: Ensor, H, և այլն
Հրապարակվել է: (2011)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia in UK MRC trials.
‌: Harrison, C, և այլն
Հրապարակվել է: (2003)

Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial).
‌: de la Fuente, J, և այլն
Հրապարակվել է: (2005)

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
‌: Moorman, A, և այլն
Հրապարակվել է: (2010)

The clinical pharmacology of thioguanine vs. mercaptopurine in ALL97, a randomized trial for the treatment of childhood lymphoblastic leukaemia
‌: Lennard, L, և այլն
Հրապարակվել է: (2008)

The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
‌: Lennard, L, և այլն
Հրապարակվել է: (2010)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
‌: Chessells, J, և այլն
Հրապարակվել է: (1994)

A third intensive block of treatment at 35 weeks improves outcome in childhood ALL: Preliminary results from the UKALLXI and ALL97 randomised trials.
‌: Richards, S, և այլն
Հրապարակվել է: (1998)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
‌: Moorman, A, և այլն
Հրապարակվել է: (2007)

Thioguanine versus mercaptopurine in ALL97: thiopurine metabolism and treatment outcome
‌: Lennard, L, և այլն
Հրապարակվել է: (2008)

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
‌: Vora, A, և այլն
Հրապարակվել է: (2008)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
‌: Moorman, A, և այլն
Հրապարակվել է: (2005)

Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
‌: Moorman, A, և այլն
Հրապարակվել է: (2013)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
‌: Chessells, J, և այլն
Հրապարակվել է: (1995)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.
‌: Harrison, C, և այլն
Հրապարակվել է: (2004)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
‌: Chessells, J, և այլն
Հրապարակվել է: (1997)

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).
‌: Moorman, A, և այլն
Հրապարակվել է: (2007)

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.
‌: Kinsey, S, և այլն
Հրապարակվել է: (2002)

Clinical significance of blast cell karyotype change at relapse of childhood ALL.
‌: Vora, A, և այլն
Հրապարակվել է: (1996)

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods.
‌: Eden, O, և այլն
Հրապարակվել է: (1990)

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.
‌: Moorman, A, և այլն
Հրապարակվել է: (2003)

The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)
‌: Moorman, A, և այլն
Հրապարակվել է: (2008)

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
‌: Vora, A, և այլն
Հրապարակվել է: (2006)

ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.
‌: Martineau, M, և այլն
Հրապարակվել է: (2005)

Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
‌: Hill, F, և այլն
Հրապարակվել է: (2004)

Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.
‌: Krishnan, S, և այլն
Հրապարակվել է: (2010)

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
‌: Ramanujachar, R, և այլն
Հրապարակվել է: (2007)

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
‌: Sive, J, և այլն
Հրապարակվել է: (2012)

Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
‌: Hann, I, և այլն
Հրապարակվել է: (1998)

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.
‌: Robinson, H, և այլն
Հրապարակվել է: (2003)